Christopher Freeman

Christopher Freeman

Chief Commercial OfficeratGuardant Health· In proxies 2021–2023

Pay in FY2023-11% from the year before · Guardant Health stock -0.6% the same year

Christopher Freeman was paid $3.5M in FY2023 (Dec), down 11%. Guardant Health stock fell 0.6% that year.

Pay$100 in the stock at the end of FY20 → $21
Pay is from the Summary Compensation Table of each Guardant Health proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Guardant HealthPublic company · 5 yr
    • Chief Commercial Officer2021 – Present · 5 yrStock in role +36%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?